AHA opposes tariffs imposed on medical equipment, products

Nov 05, 2018 - 03:42 PM
AHA-comment

The AHA opposes tariffs that have been imposed on medical equipment and medical products imported from China that are used in hospitals, as well as potential tariffs under consideration that would impact the health care field. 
  
"The imposition of these tariffs will increase the cost of providing health care to all Americans, hitting vulnerable communities, such as rural communities that can least afford higher costs, especially hard," AHA wrote today to Commerce Secretary Wilbur Ross. 
  
According to the Association for Health Care Resource & Materials Management, an AHA professional membership group, the recent tariffs are estimated to increase the cost of medical equipment and supplies typically purchased by hospitals and health systems by at least $160 million per year. This amount does not include the additional costs due to tariffs that hospitals will incur during construction for steel or when acquiring major appliances so the overall impact on hospitals and health systems is greater and will certainly lead to higher health care costs, AHA noted. 
  
"We urge the Administration to find alternatives to tariffs and to work with stakeholders to consider the impact of potential trade actions," AHA wrote. "The AHA asks the Administration to enact policies that make health care more affordable so that every American can reach their highest potential for health."

Related News Articles

Headline
FDA finalizes recommendations simplifying approval process for medical devices that use AI
FDA finalizes recommendations simplifying approval process for medical devices that use AI The Food and Drug Administration yesterday released…
Headline
FDA clarifies definition of 'remanufacturing' for medical devices needing maintenance
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
FDA webinar Oct. 31 on proposed rule for laboratory developed tests 
On Oct. 31 at 1 p.m. ET, the Food and Drug Administration will host a webinar to review its recent proposed rule for laboratory developed tests,…
Headline
FDA updates sterilization standards for medical device makers
The Food and Drug Administration the week of July 24 updated its recognized consensus standards database for medical devices to advance innovation in medical…
Headline
FDA releases transition plans for medical device enforcement, authorization after COVID-19 public health emergency
The Food and Drug Administration today released final guidance for transitioning medical device enforcement policies and emergency use authorizations…
Headline
FDA seeks input for future guidance on 3D printing at the point of care
The Food and Drug Administration Friday released a discussion paper on 3D printing of medical devices at the point of care to facilitate input from…